Monitoring cardiovascular function in infants with chronic lung disease of prematurity

Abman, S.H.
July 2002
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2002, Vol. 87 Issue 1, pF15
Academic Journal
In addition to persistent airways disease, survivors of premature birth with chronic lung disease are at risk of cardiovascular sequelae, including pulmonary hypertension, systemic hypertension, left ventricular hypertrophy, and exercise intolerance. The major treatment of pulmonary hypertension is supplemental oxygen, but drugs such as calcium channel blockers may also be required.


Related Articles

  • A Treatment Algorithm for Pulmonary Arterial Hypertension. Galiè, Nazzareno // Advances in Pulmonary Hypertension;2014, Vol. 13 Issue 1, p31 

    The treatment algorithm for pulmonary arterial hypertension (PAH) represents graphically a sequence of operations that are needed for the management of patients. The treatment algorithm includes different types of recommendations with varying degrees of scientific evidence. The recommendations...

  • Pulmonary arterial hypertension: Bridging the gap between efficacy, quality of life, and cost-effectiveness. Gandhi, Raj; Baker, Nicholas; Shek, Allen; Yeh, Jonathan; Bishop, Dale // Formulary;Jun2010, Vol. 45 Issue 6, p190 

    The article discusses pharmacological treatment options for patients with pulmonary arterial hypertension (PAH). PAH is a significant risk factor for right-side heart failure and death. Various classes of drugs are used in the treatment of PAH including calcium channel blockers and...

  • Acute Effects of Aerosolized Iloprost in COPD Related Pulmonary Hypertension - A Randomized Controlled Crossover Trial Boeck, Lucas; Tamm, Michael; Grendelmeier, Peter; Stolz, Daiana // PLoS Clinical Trials;Dec2012, Vol. 7 Issue 12, p1 

    Background: Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension (PH). Objectives: To evaluate acute effects of aerosolized iloprost in patients with COPD-associated PH. ...

  • Calcium channel blockers ease GI symptoms. Geyerhahn, George; Baker, James M. // Cortlandt Forum;6/25/95, Vol. 8 Issue 6, p8 

    Comments on positive side effects of calcium channel blockers in patients with diarrhea or irritable bowel syndrome (IBS). Constipation as a result in one patient; Relaxation of smooth muscles.

  • Newest calcium antagonist offers added features.  // Drug Topics;7/7/97, Vol. 141 Issue 13, p7 

    States that Posicor (mibefradil), from the category of tetralol calcium antagonist has been approved for the treatment of hypertension and chronic stable angina pectoris. Benefits of the drug.

  • Calcium blockers receive `PRAISE' as an addition to heart failure arsenal.  // Modern Medicine;May95, Vol. 63 Issue 5, p30 

    Reports on the therapeutic benefits of calcium channel blockers for patients with class III or IV heart failure. Study results from the Prospective Randomized Amlodipine Survival Evaluaton (PRAISE); Patient toleration of calcium blockers; Mortality results.

  • Is the Use of Some Calcium Antagonists Linked to Cancer?: Evidence From Recent Observational Studies. Pahor, M.; Furberg, C.D. // Drugs & Aging;1998, Vol. 13 Issue 2, p99 

    In animal and in vitro studies, several calcium antagonists have been shown to block apoptosis (programmed cell death), a natural cellular defence against cancer. On the basis of these studies, it has been hypothesised that calcium antagonists may function as cancer promoters and that they might...

  • Neurotrophins expression is decreased in lungs of human infants with congenital diaphragmatic hernia. O'hanlon, Lynn D.; Mabry, Sherry M.; Ekekezie, Ikechukwu I. // Research & Reports in Neonatology;2014, Vol. 4, p9 

    Objectives: To evaluate neurotrophin (NT) (nerve growth factor [NGF], NT-3, and brain-derived neurotrophic factor [BDNF]) expression in autopsy lung tissues of human congenital diaphragmatic hernia (CDH) infants versus that of infants that expired with: 1) "normal" lungs (controls); 2) chronic...

  • The Story of Oxygen. Heffner, John E. // Respiratory Care;Jan2013, Vol. 58 Issue 1, p18 

    The history of oxygen from discovery to clinical application for patients with chronic lung disease represents a long and storied journey. Within a relatively short period, early investigators not only discovered oxygen but also recognized its importance to life and its role in respiration. The...


Read the Article


Sign out of this library

Other Topics